ALAB vs PATH · P/E 78, rev $396.3M vs P/E 19, rev $1.61B
Astera Labs, Inc. Common Stock (ALAB) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
Astera Labs, Inc. Common Stock (ALAB) is a semiconductors company listed on US.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported ALAB revenue for 2024-12-31 was $396.3M. Net income was -$83.4M. Revenue was up 242.2% from 2023-12-31 to 2024-12-31. ALAB currently screens at market cap $16.84B and trailing P/E 78.0.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
ALAB currently screens at market cap $16.84B and trailing P/E 78.0. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the ALAB and PATH stock pages for the full models.
Not investment advice.